Exagen Stock Forecast
NASDAQ: XGNHealth CareMedical SpecialitiesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
XGN analyst consensus
Consensus (7 analysts)
none
Avg. price target
$10.14+24.11%
- Strong buy 0
- Buy 7
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering Exagen (2026-10-08), 7 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $10.14, with a high estimate of $12.00 and a low estimate of $9.00. The average target implies upside of 24.1% from the current price of $8.17.
The spread between the highest and lowest targets is 33.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for XGN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 7 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $9.00 | +10.16% |
| Average target | $10.14 | +24.11% |
| High target | $12.00 | +46.88% |